{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T07:35:20Z","timestamp":1770017720062,"version":"3.49.0"},"reference-count":138,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"publisher","award":["POCI-01-0145-FEDER-016607"],"award-info":[{"award-number":["POCI-01-0145-FEDER-016607"]}],"id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"publisher","award":["PTDC\/IMI-MIC\/1049\/ 2014"],"award-info":[{"award-number":["PTDC\/IMI-MIC\/1049\/ 2014"]}],"id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Infectious Diseases"],"published-print":{"date-parts":[[2021,7]]},"DOI":"10.1016\/s1473-3099(20)30602-2","type":"journal-article","created":{"date-parts":[[2020,12,24]],"date-time":"2020-12-24T00:50:55Z","timestamp":1608771055000},"page":"e191-e201","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":35,"title":["To give or not to give antibiotics is not the only question"],"prefix":"10.1016","volume":"21","author":[{"given":"Catarina","family":"Magalh\u00e3es","sequence":"first","affiliation":[]},{"given":"Margarida","family":"Lima","sequence":"additional","affiliation":[]},{"given":"Patrick","family":"Trieu-Cuot","sequence":"additional","affiliation":[]},{"given":"Paula","family":"Ferreira","sequence":"additional","affiliation":[]}],"member":"78","reference":[{"key":"10.1016\/S1473-3099(20)30602-2_bib1","first-page":"226","article-title":"On the antibacterial action of cultures of a penicillium, with special reference to their use in the isolation of B. influenza","volume":"10","author":"Fleming","year":"1929","journal-title":"Br J Exp Pathol"},{"key":"10.1016\/S1473-3099(20)30602-2_bib2","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1007\/BF01828193","article-title":"Zur Frage der salvarsanresistenten Lues","volume":"147","author":"Silberstein","year":"1924","journal-title":"Arch Dermatol Syph"},{"key":"10.1016\/S1473-3099(20)30602-2_bib3","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1038\/d41586-018-06983-0","article-title":"First report of antimicrobial resistance pre-dates penicillin","volume":"562","author":"Stekel","year":"2018","journal-title":"Nature"},{"key":"10.1016\/S1473-3099(20)30602-2_bib4","doi-asserted-by":"crossref","first-page":"135","DOI":"10.7326\/0003-4819-149-2-200807150-00009","article-title":"The first use of penicillin in the United States","volume":"149","author":"Grossman","year":"2008","journal-title":"Ann Intern Med"},{"key":"10.1016\/S1473-3099(20)30602-2_bib5","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1093\/ajcp\/15.10.446","article-title":"Penicillin resistance of Staphylococcus aureus and its clinical implications","volume":"15","author":"Plough","year":"1945","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/S1473-3099(20)30602-2_bib6","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1136\/jcp.14.4.385","article-title":"Methicillin-resistant staphylococci","volume":"14","author":"Barber","year":"1961","journal-title":"J Clin Pathol"},{"key":"10.1016\/S1473-3099(20)30602-2_bib7","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1056\/NEJM196808292790901","article-title":"Methicillin-resistant Staphylococcus aureus at Boston City Hospital. Bacteriologic and epidemiologic observations","volume":"279","author":"Barrett","year":"1968","journal-title":"N Engl J Med"},{"key":"10.1016\/S1473-3099(20)30602-2_bib8","doi-asserted-by":"crossref","DOI":"10.1038\/nrdp.2018.33","article-title":"Methicillin-resistant Staphylococcus aureus","volume":"4","author":"Lee","year":"2018","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/S1473-3099(20)30602-2_bib9","doi-asserted-by":"crossref","first-page":"2836","DOI":"10.1172\/JCI68834","article-title":"Mechanisms of vancomycin resistance in Staphylococcus aureus","volume":"124","author":"Gardete","year":"2014","journal-title":"J Clin Invest"},{"key":"10.1016\/S1473-3099(20)30602-2_bib10","series-title":"Tackling drug-resistant infections globally: final report and recommendations","author":"O'Neill","year":"2016"},{"key":"10.1016\/S1473-3099(20)30602-2_bib11","author":"Lindmeier"},{"key":"10.1016\/S1473-3099(20)30602-2_bib12","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/S1473-3099(18)30122-1","article-title":"Sustained transmission of high-level azithromycin-resistant Neisseria gonorrhoeae in England: an observational study","volume":"18","author":"Fifer","year":"2018","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/S1473-3099(20)30602-2_bib13","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2017-016264","article-title":"Guideline recommendations and antimicrobial resistance: the need for a change","volume":"7","author":"Elias","year":"2017","journal-title":"BMJ Open"},{"key":"10.1016\/S1473-3099(20)30602-2_bib14","series-title":"Antibacterial agents in clinical development: an analysis of the antibacterial clinical development pipeline, including tuberculosis","year":"2017"},{"key":"10.1016\/S1473-3099(20)30602-2_bib15","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.mib.2017.10.028","article-title":"Global antimicrobial resistance in Gram-negative pathogens and clinical need","volume":"39","author":"Theuretzbacher","year":"2017","journal-title":"Curr Opin Microbiol"},{"key":"10.1016\/S1473-3099(20)30602-2_bib16","doi-asserted-by":"crossref","first-page":"2323","DOI":"10.1001\/jama.2009.1754","article-title":"International study of the prevalence and outcomes of infection in intensive care units","volume":"302","author":"Vincent","year":"2009","journal-title":"JAMA"},{"key":"10.1016\/S1473-3099(20)30602-2_bib17","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/S0140-6736(05)17907-0","article-title":"Outpatient antibiotic use in Europe and association with resistance: a cross-national database study","volume":"365","author":"Goossens","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/S1473-3099(20)30602-2_bib18","series-title":"Antimicrobial consumption in the EU\/EEA: annual epidemiological report for 2018","year":"2019"},{"key":"10.1016\/S1473-3099(20)30602-2_bib19","series-title":"Surveillance of antimicrobial resistance in Europe 2018","year":"2019"},{"key":"10.1016\/S1473-3099(20)30602-2_bib20","series-title":"Antibiotic resistance threats in the United States, 2013","year":"2013"},{"key":"10.1016\/S1473-3099(20)30602-2_bib21","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1086\/517384","article-title":"Trends in antimicrobial drug use in the community\u2013France, 1981\u20131992","volume":"177","author":"Guillemot","year":"1998","journal-title":"J Infect Dis"},{"key":"10.1016\/S1473-3099(20)30602-2_bib22","article-title":"The antibiotic course has had its day","volume":"358","author":"Llewelyn","year":"2017","journal-title":"BMJ"},{"key":"10.1016\/S1473-3099(20)30602-2_bib24","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1016\/S0140-6736(00)04519-0","article-title":"Persistence of sulphonamide resistance in Escherichia coli in the UK despite national prescribing restriction","volume":"357","author":"Enne","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/S1473-3099(20)30602-2_bib25","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1093\/clinids\/1.1.4","article-title":"Emergence of antibiotic resistance in hospitals, 1935\u20131975","volume":"1","author":"Finland","year":"1979","journal-title":"Rev Infect Dis"},{"key":"10.1016\/S1473-3099(20)30602-2_bib26","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1056\/NEJM199708143370701","article-title":"The effect of changes in the consumption of macrolide antibiotics on erythromycin resistance in group A streptococci in Finland","volume":"337","author":"Sepp\u00e4l\u00e4","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1016\/S1473-3099(20)30602-2_bib27","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.2217\/fmb.12.117","article-title":"Emergence of multidrug-resistant, extensively drug-resistant and untreatable gonorrhea","volume":"7","author":"Unemo","year":"2012","journal-title":"Future Microbiol"},{"key":"10.1016\/S1473-3099(20)30602-2_bib28","series-title":"The world medicines situation 2011: rational use of medicines","author":"Holloway","year":"2011"},{"key":"10.1016\/S1473-3099(20)30602-2_bib29","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/S1473-3099(16)00065-7","article-title":"Current evidence on hospital antimicrobial stewardship objectives: a systematic review and meta-analysis","volume":"16","author":"Schuts","year":"2016","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/S1473-3099(20)30602-2_bib30","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1093\/cid\/cit688","article-title":"Appropriate antibiotic use for patients with urinary tract infections reduces length of hospital stay","volume":"58","author":"Spoorenberg","year":"2014","journal-title":"Clin Infect Dis"},{"key":"10.1016\/S1473-3099(20)30602-2_bib31","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1038\/sj.bdj.2018.525","article-title":"Antibiotic resistance and antibiotic prescribing by dentists in England 2007\u20132016","volume":"225","author":"Bunce","year":"2018","journal-title":"Br Dent J"},{"key":"10.1016\/S1473-3099(20)30602-2_bib32","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.2001586","article-title":"History of antibiotic adaptation influences microbial evolutionary dynamics during subsequent treatment","volume":"15","author":"Yen","year":"2017","journal-title":"PLoS Biol"},{"key":"10.1016\/S1473-3099(20)30602-2_bib33","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1128\/AAC.00851-06","article-title":"Clinical prediction tool to identify patients with Pseudomonas aeruginosa respiratory tract infections at greatest risk for multidrug resistance","volume":"51","author":"Lodise","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/S1473-3099(20)30602-2_bib34","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.3000515","article-title":"Pervasive and diverse collateral sensitivity profiles inform optimal strategies to limit antibiotic resistance","volume":"17","author":"Maltas","year":"2019","journal-title":"PLoS Biol"},{"key":"10.1016\/S1473-3099(20)30602-2_bib35","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/S1473-3099(18)30056-2","article-title":"The effects of antibiotic cycling and mixing on antibiotic resistance in intensive care units: a cluster-randomised crossover trial","volume":"18","author":"van Duijn","year":"2018","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/S1473-3099(20)30602-2_bib36","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3006609","article-title":"Use of collateral sensitivity networks to design drug cycling protocols that avoid resistance development","volume":"5","author":"Imamovic","year":"2013","journal-title":"Sci Transl Med"},{"key":"10.1016\/S1473-3099(20)30602-2_bib37","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1093\/molbev\/msv006","article-title":"Collateral resistance and sensitivity modulate evolution of high-level resistance to drug combination treatment in Staphylococcus aureus","volume":"32","author":"Rodriguez de Evgrafov","year":"2015","journal-title":"Mol Biol Evol"},{"key":"10.1016\/S1473-3099(20)30602-2_bib38","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.cell.2017.12.012","article-title":"Drug-driven phenotypic convergence supports rational treatment strategies of chronic infections","volume":"172","author":"Imamovic","year":"2018","journal-title":"Cell"},{"key":"10.1016\/S1473-3099(20)30602-2_bib39","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1038\/nrmicro3380","article-title":"Molecular mechanisms of antibiotic resistance","volume":"13","author":"Blair","year":"2015","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/S1473-3099(20)30602-2_bib40","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/j.ijmm.2010.08.009","article-title":"Mutators in cystic fibrosis chronic lung infection: prevalence, mechanisms, and consequences for antimicrobial therapy","volume":"300","author":"Oliver","year":"2010","journal-title":"Int J Med Microbiol"},{"key":"10.1016\/S1473-3099(20)30602-2_bib41","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/BF00182388","article-title":"Role of interspecies transfer of chromosomal genes in the evolution of penicillin resistance in pathogenic and commensal Neisseria species","volume":"34","author":"Spratt","year":"1992","journal-title":"J Mol Evol"},{"key":"10.1016\/S1473-3099(20)30602-2_bib42","doi-asserted-by":"crossref","first-page":"8842","DOI":"10.1073\/pnas.86.22.8842","article-title":"Horizontal transfer of penicillin-binding protein genes in penicillin-resistant clinical isolates of Streptococcus pneumoniae","volume":"86","author":"Dowson","year":"1989","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/S1473-3099(20)30602-2_bib43","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1111\/j.1365-2958.1993.tb01723.x","article-title":"Evolution of penicillin resistance in Streptococcus pneumoniae; the role of Streptococcus mitis in the formation of a low affinity PBP2B in S. pneumoniae","volume":"9","author":"Dowson","year":"1993","journal-title":"Mol Microbial"},{"key":"10.1016\/S1473-3099(20)30602-2_bib44","doi-asserted-by":"crossref","first-page":"5574","DOI":"10.1128\/jb.176.17.5574-5577.1994","article-title":"Penicillin-binding protein 2b of Streptococcus pneumoniae in piperacillin-resistant laboratory mutants","volume":"176","author":"Hakenbeck","year":"1994","journal-title":"J Bacteriol"},{"key":"10.1016\/S1473-3099(20)30602-2_bib45","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.1574-6968.1987.tb02558.x","article-title":"Plasmid transfer by conjugation from Escherichia coli to Gram-positive bacteria","volume":"48","author":"Trieu-Cuot","year":"1987","journal-title":"FEMS Microbiol Lett"},{"key":"10.1016\/S1473-3099(20)30602-2_bib46","doi-asserted-by":"crossref","first-page":"4388","DOI":"10.1128\/jb.170.9.4388-4391.1988","article-title":"Conjugative plasmid transfer from Enterococcus faecalis to Escherichia coli","volume":"170","author":"Trieu-Cuot","year":"1988","journal-title":"J Bacteriol"},{"key":"10.1016\/S1473-3099(20)30602-2_bib47","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1038\/nrg3922","article-title":"Evolutionary consequences of drug resistance: shared principles across diverse targets and organisms","volume":"16","author":"Hughes","year":"2015","journal-title":"Nat Rev Genet"},{"key":"10.1016\/S1473-3099(20)30602-2_bib48","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-018-30972-y","article-title":"Mutations causing low level antibiotic resistance ensure bacterial survival in antibiotic-treated hosts","volume":"8","author":"Frimodt-M\u00f8ller","year":"2018","journal-title":"Sci Rep"},{"key":"10.1016\/S1473-3099(20)30602-2_bib49","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1038\/nrmicro2319","article-title":"Antibiotic resistance and its cost: is it possible to reverse resistance?","volume":"8","author":"Andersson","year":"2010","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/S1473-3099(20)30602-2_bib50","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/1471-2334-14-13","article-title":"A systematic review and meta-analysis of the effects of antibiotic consumption on antibiotic resistance","volume":"14","author":"Bell","year":"2014","journal-title":"BMC Infect Dis"},{"key":"10.1016\/S1473-3099(20)30602-2_bib51","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S1473-3099(01)00066-4","article-title":"Effect of antimicrobial agents on the ecological balance of human microflora","volume":"1","author":"Sullivan","year":"2001","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/S1473-3099(20)30602-2_bib52","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1038\/nature12212","article-title":"Antibiotic treatment expands the resistance reservoir and ecological network of the phage metagenome","volume":"499","author":"Modi","year":"2013","journal-title":"Nature"},{"key":"10.1016\/S1473-3099(20)30602-2_bib53","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1126\/science.1232751","article-title":"Cell death from antibiotics without the involvement of reactive oxygen species","volume":"339","author":"Liu","year":"2013","journal-title":"Science"},{"key":"10.1016\/S1473-3099(20)30602-2_bib54","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1126\/science.1232688","article-title":"Killing by bactericidal antibiotics does not depend on reactive oxygen species","volume":"339","author":"Keren","year":"2013","journal-title":"Science"},{"key":"10.1016\/S1473-3099(20)30602-2_bib55","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/j.cell.2007.06.049","article-title":"A common mechanism of cellular death induced by bactericidal antibiotics","volume":"130","author":"Kohanski","year":"2007","journal-title":"Cell"},{"key":"10.1016\/S1473-3099(20)30602-2_bib56","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.tim.2016.12.008","article-title":"The role of reactive oxygen species in antibiotic-mediated killing of bacteria","volume":"25","author":"Van Acker","year":"2017","journal-title":"Trends Microbiol"},{"key":"10.1016\/S1473-3099(20)30602-2_bib57","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1111\/1574-6976.12077","article-title":"SOS, the formidable strategy of bacteria against aggressions","volume":"38","author":"Baharoglu","year":"2014","journal-title":"FEMS Microbiol Rev"},{"key":"10.1016\/S1473-3099(20)30602-2_bib58","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0178303","article-title":"Zinc blocks SOS-induced antibiotic resistance via inhibition of RecA in Escherichia coli","volume":"12","author":"Bunnell","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/S1473-3099(20)30602-2_bib59","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.tim.2016.02.009","article-title":"The use and abuse of LexA by mobile genetic elements","volume":"24","author":"Fornelos","year":"2016","journal-title":"Trends Microbiol"},{"key":"10.1016\/S1473-3099(20)30602-2_bib60","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1002778","article-title":"Evidence for induction of integron-based antibiotic resistance by the SOS response in a clinical setting","volume":"8","author":"Hocquet","year":"2012","journal-title":"PLoS Pathog"},{"key":"10.1016\/S1473-3099(20)30602-2_bib61","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/j.molmed.2016.04.003","article-title":"Antibiotic-induced changes in the intestinal microbiota and disease","volume":"22","author":"Becattini","year":"2016","journal-title":"Trends Mol Med"},{"key":"10.1016\/S1473-3099(20)30602-2_bib62","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1038\/nature02241","article-title":"SOS response promotes horizontal dissemination of antibiotic resistance genes","volume":"427","author":"Beaber","year":"2004","journal-title":"Nature"},{"key":"10.1016\/S1473-3099(20)30602-2_bib63","doi-asserted-by":"crossref","first-page":"e00569","DOI":"10.1128\/mBio.00569-13","article-title":"Regulation of CTnDOT conjugative transfer is a complex and highly coordinated series of events","volume":"4","author":"Waters","year":"2013","journal-title":"mBio"},{"key":"10.1016\/S1473-3099(20)30602-2_bib64","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1046\/j.1365-2958.1998.00778.x","article-title":"Circularization of Tn916 is required for expression of the transposon-encoded transfer functions: characterization of long tetracycline-inducible transcripts reading through the attachment site","volume":"28","author":"Celli","year":"1998","journal-title":"Mol Microbiol"},{"key":"10.1016\/S1473-3099(20)30602-2_bib65","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/j.1574-6968.1993.tb06137.x","article-title":"Enhanced conjugative transfer of plasmid DNA from Escherichia coli to Staphylococcus aureus and Listeria monocytogenes","volume":"109","author":"Trieu-Cuot","year":"1993","journal-title":"FEMS Microbiol Lett"},{"key":"10.1016\/S1473-3099(20)30602-2_bib66","first-page":"e02331","article-title":"Bacterial quorum sensing and microbial community interactions","volume":"9","author":"Abisado","year":"2018","journal-title":"mBio"},{"key":"10.1016\/S1473-3099(20)30602-2_bib67","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.tim.2017.10.005","article-title":"Quorum-sensing systems as targets for antivirulence therapy","volume":"26","author":"Defoirdt","year":"2018","journal-title":"Trends Microbiol"},{"key":"10.1016\/S1473-3099(20)30602-2_bib68","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0147698","article-title":"Impact of azithromycin on the quorum sensing-controlled proteome of Pseudomonas aeruginosa","volume":"11","author":"Swatton","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/S1473-3099(20)30602-2_bib69","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.jgar.2017.03.006","article-title":"Inhibition of Pseudomonas aeruginosa quorum sensing by subinhibitory concentrations of curcumin with gentamicin and azithromycin","volume":"10","author":"Bahari","year":"2017","journal-title":"J Glob Antimicrob Resist"},{"key":"10.1016\/S1473-3099(20)30602-2_bib70","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1086\/511642","article-title":"Mutant selection window hypothesis updated","volume":"44","author":"Drlica","year":"2007","journal-title":"Clin Infect Dis"},{"key":"10.1016\/S1473-3099(20)30602-2_bib71","doi-asserted-by":"crossref","first-page":"8787","DOI":"10.3748\/wjg.v21.i29.8787","article-title":"Role of the normal gut microbiota","volume":"21","author":"Jandhyala","year":"2015","journal-title":"World J Gastroenterol"},{"key":"10.1016\/S1473-3099(20)30602-2_bib72","doi-asserted-by":"crossref","first-page":"13780","DOI":"10.1073\/pnas.0706625104","article-title":"Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases","volume":"104","author":"Frank","year":"2007","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/S1473-3099(20)30602-2_bib73","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1038\/nature07540","article-title":"A core gut microbiome in obese and lean twins","volume":"457","author":"Turnbaugh","year":"2009","journal-title":"Nature"},{"key":"10.1016\/S1473-3099(20)30602-2_bib74","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1038\/nrd2505","article-title":"Gut microbiota: a potential new territory for drug targeting","volume":"7","author":"Jia","year":"2008","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/S1473-3099(20)30602-2_bib75","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.tim.2004.07.004","article-title":"Human intestinal bacteria as reservoirs for antibiotic resistance genes","volume":"12","author":"Salyers","year":"2004","journal-title":"Trends Microbiol"},{"key":"10.1016\/S1473-3099(20)30602-2_bib76","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1038\/nature06245","article-title":"An ecological and evolutionary perspective on human-microbe mutualism and disease","volume":"449","author":"Dethlefsen","year":"2007","journal-title":"Nature"},{"key":"10.1016\/S1473-3099(20)30602-2_bib77","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1038\/nature09199","article-title":"Viruses in the faecal microbiota of monozygotic twins and their mothers","volume":"466","author":"Reyes","year":"2010","journal-title":"Nature"},{"key":"10.1016\/S1473-3099(20)30602-2_bib78","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1126\/science.1174463","article-title":"Bacteriophages encode factors required for protection in a symbiotic mutualism","volume":"325","author":"Oliver","year":"2009","journal-title":"Science"},{"key":"10.1016\/S1473-3099(20)30602-2_bib79","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1038\/nrmicro2989","article-title":"\u2018Blooming\u2019 in the gut: how dysbiosis might contribute to pathogen evolution","volume":"11","author":"Stecher","year":"2013","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/S1473-3099(20)30602-2_bib80","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1073\/pnas.1113246109","article-title":"Gut inflammation can boost horizontal gene transfer between pathogenic and commensal Enterobacteriaceae","volume":"109","author":"Stecher","year":"2012","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/S1473-3099(20)30602-2_bib81","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aad0917","article-title":"Natural history of the infant gut microbiome and impact of antibiotic treatment on bacterial strain diversity and stability","volume":"8","author":"Yassour","year":"2016","journal-title":"Sci Transl Med"},{"key":"10.1016\/S1473-3099(20)30602-2_bib82","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1038\/nature12503","article-title":"Microbiota-liberated host sugars facilitate post-antibiotic expansion of enteric pathogens","volume":"502","author":"Ng","year":"2013","journal-title":"Nature"},{"key":"10.1016\/S1473-3099(20)30602-2_bib83","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1093\/jac\/dkp128","article-title":"Temporal effects of antibiotic use and Clostridium difficile infections","volume":"63","author":"Vernaz","year":"2009","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/S1473-3099(20)30602-2_bib84","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.1056\/NEJMra0707500","article-title":"Clostridium difficile\u2014more difficult than ever","volume":"359","author":"Kelly","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/S1473-3099(20)30602-2_bib85","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.amjsurg.2016.10.035","article-title":"Clostridium difficile colitis: a clinical review","volume":"213","author":"Ong","year":"2017","journal-title":"Am J Surg"},{"key":"10.1016\/S1473-3099(20)30602-2_bib86","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1093\/jac\/dkt477","article-title":"Antibiotics and hospital-acquired Clostridium difficile infection: update of systematic review and meta-analysis","volume":"69","author":"Slimings","year":"2014","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/S1473-3099(20)30602-2_bib87","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1136\/gutjnl-2012-303184","article-title":"Gut microbiota disturbance during antibiotic therapy: a multi-omic approach","volume":"62","author":"P\u00e9rez-Cobas","year":"2013","journal-title":"Gut"},{"issue":"suppl 1","key":"10.1016\/S1473-3099(20)30602-2_bib88","doi-asserted-by":"crossref","first-page":"4554","DOI":"10.1073\/pnas.1000087107","article-title":"Incomplete recovery and individualized responses of the human distal gut microbiota to repeated antibiotic perturbation","volume":"108","author":"Dethlefsen","year":"2011","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/S1473-3099(20)30602-2_bib89","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1038\/ismej.2007.3","article-title":"Long-term ecological impacts of antibiotic administration on the human intestinal microbiota","volume":"1","author":"Jernberg","year":"2007","journal-title":"ISME J"},{"key":"10.1016\/S1473-3099(20)30602-2_bib90","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1038\/s41564-018-0257-9","article-title":"Recovery of gut microbiota of healthy adults following antibiotic exposure","volume":"3","author":"Palleja","year":"2018","journal-title":"Nat Microbiol"},{"key":"10.1016\/S1473-3099(20)30602-2_bib91","doi-asserted-by":"crossref","first-page":"722","DOI":"10.3389\/fmicb.2014.00722","article-title":"Antimicrobial resistance characteristics and fitness of Gram-negative fecal bacteria from volunteers treated with minocycline or amoxicillin","volume":"5","author":"Kirchner","year":"2014","journal-title":"Front Microbiol"},{"key":"10.1016\/S1473-3099(20)30602-2_bib92","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1093\/jac\/dkl420","article-title":"Clindamycin-induced enrichment and long-term persistence of resistant Bacteroides spp. and resistance genes","volume":"58","author":"L\u00f6fmark","year":"2006","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/S1473-3099(20)30602-2_bib93","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.3201\/eid1109.050124","article-title":"Persistence of resistant Staphylococcus epidermidis after single course of clarithromycin","volume":"11","author":"Sj\u00f6lund","year":"2005","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/S1473-3099(20)30602-2_bib94","doi-asserted-by":"crossref","first-page":"483","DOI":"10.7326\/0003-4819-139-6-200309160-00011","article-title":"Long-term persistence of resistant Enterococcus species after antibiotics to eradicate Helicobacter pylori","volume":"139","author":"Sj\u00f6lund","year":"2003","journal-title":"Ann Intern Med"},{"key":"10.1016\/S1473-3099(20)30602-2_bib95","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.c2096","article-title":"Effect of antibiotic prescribing in primary care on antimicrobial resistance in individual patients: systematic review and meta-analysis","volume":"340","author":"Costelloe","year":"2010","journal-title":"BMJ"},{"key":"10.1016\/S1473-3099(20)30602-2_bib96","doi-asserted-by":"crossref","first-page":"1996","DOI":"10.1056\/NEJMoa1411162","article-title":"Trial of short-course antimicrobial therapy for intraabdominal infection","volume":"372","author":"Sawyer","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/S1473-3099(20)30602-2_bib97","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1016\/S0140-6736(14)61233-2","article-title":"Antibiotic treatment for 6 weeks versus 12 weeks in patients with pyogenic vertebral osteomyelitis: an open-label, non-inferiority, randomised, controlled trial","volume":"385","author":"Bernard","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/S1473-3099(20)30602-2_bib98","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1097\/CCM.0000000000001393","article-title":"Duration of antimicrobial treatment for bacteremia in Canadian critically ill patients","volume":"44","author":"Daneman","year":"2016","journal-title":"Crit Care Med"},{"key":"10.1016\/S1473-3099(20)30602-2_bib99","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1093\/cid\/ciy1054","article-title":"Seven versus 14 days of antibiotic therapy for uncomplicated Gram-negative bacteremia: a non-inferiority randomized controlled trial","volume":"69","author":"Yahav","year":"2019","journal-title":"Clin Infect Dis"},{"key":"10.1016\/S1473-3099(20)30602-2_bib100","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1093\/cid\/cix767","article-title":"Comparing the outcomes of adults with Enterobacteriaceae bacteremia receiving short-course versus prolonged-course antibiotic therapy in a multicenter, propensity score-matched cohort","volume":"66","author":"Chotiprasitsakul","year":"2018","journal-title":"Clin Infect Dis"},{"key":"10.1016\/S1473-3099(20)30602-2_bib101","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/j.cmi.2018.09.018","article-title":"Impact of antimicrobial treatment duration on outcome of Staphylococcus aureus bacteraemia: a cohort study","volume":"25","author":"Kim","year":"2019","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/S1473-3099(20)30602-2_bib102","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1136\/bmj.317.7159.663","article-title":"Regulating the use of antibiotics in the community","volume":"317","author":"Carbon","year":"1998","journal-title":"BMJ"},{"key":"10.1016\/S1473-3099(20)30602-2_bib103","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.332.7554.1355","article-title":"Effectiveness of discontinuing antibiotic treatment after three days versus eight days in mild to moderate-severe community acquired pneumonia: randomised, double blind study","volume":"332","author":"el Moussaoui","year":"2006","journal-title":"BMJ"},{"key":"10.1016\/S1473-3099(20)30602-2_bib104","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1136\/bmj.38049.490255.DE","article-title":"Three day versus five day treatment with amoxicillin for non-severe pneumonia in young children: a multicentre randomised controlled trial","volume":"328","author":"Agarwal","year":"2004","journal-title":"BMJ"},{"key":"10.1016\/S1473-3099(20)30602-2_bib105","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/S0140-6736(02)09994-4","article-title":"Clinical efficacy of 3 days versus 5 days of oral amoxicillin for treatment of childhood pneumonia: a multicenter double-blind trial","volume":"360","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/S1473-3099(20)30602-2_bib106","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1001\/jama.279.5.365","article-title":"Low dosage and long treatment duration of beta-lactam: risk factors for carriage of penicillin-resistant Streptococcus pneumoniae","volume":"279","author":"Guillemot","year":"1998","journal-title":"JAMA"},{"key":"10.1016\/S1473-3099(20)30602-2_bib107","doi-asserted-by":"crossref","first-page":"654","DOI":"10.3122\/jabfm.2016.06.160065","article-title":"5-day versus 10-day course of fluoroquinolones in outpatient males with a urinary tract infection (UTI)","volume":"29","author":"Mospan","year":"2016","journal-title":"J Am Board Fam Med"},{"key":"10.1016\/S1473-3099(20)30602-2_bib108","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1007\/s11255-017-1507-0","volume":"49","author":"Ren","year":"2017","journal-title":"Int Urol Nephrol"},{"key":"10.1016\/S1473-3099(20)30602-2_bib109","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1007\/s10096-017-2951-6","article-title":"Is 5 days of oral fluoroquinolone enough for acute uncomplicated pyelonephritis? The DTP randomized trial","volume":"36","author":"Dinh","year":"2017","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/S1473-3099(20)30602-2_bib110","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1001\/jama.280.14.1233","article-title":"Class restriction of cephalosporin use to control total cephalosporin resistance in nosocomial Klebsiella","volume":"280","author":"Rahal","year":"1998","journal-title":"JAMA"},{"key":"10.1016\/S1473-3099(20)30602-2_bib112","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/S1473-3099(17)30592-3","article-title":"Effect of procalcitonin-guided antibiotic treatment on mortality in acute respiratory infections: a patient level meta-analysis","volume":"18","author":"Schuetz","year":"2018","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/S1473-3099(20)30602-2_bib113","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1056\/NEJMoa1802670","article-title":"Procalcitonin-guided use of antibiotics for lower respiratory tract infection","volume":"379","author":"Huang","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/S1473-3099(20)30602-2_bib114","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.ijid.2019.05.034","article-title":"Ineffectiveness of procalcitonin-guided antibiotic therapy in severely critically ill patients: a meta-analysis","volume":"85","author":"Peng","year":"2019","journal-title":"Int J Infect Dis"},{"key":"10.1016\/S1473-3099(20)30602-2_bib115","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1001\/jamainternmed.2016.3633","article-title":"Duration of antibiotic treatment in community-acquired pneumonia: a multicentre randomized clinical trial","volume":"176","author":"Uranga","year":"2016","journal-title":"JAMA Intern Med"},{"key":"10.1016\/S1473-3099(20)30602-2_bib116","doi-asserted-by":"crossref","first-page":"e573","DOI":"10.1016\/S2352-3026(17)30211-9","article-title":"Optimisation of empirical antimicrobial therapy in patients with haematological malignancies and febrile neutropenia (How Long study): an open-label, randomised, controlled phase 4 trial","volume":"4","author":"Aguilar-Guisado","year":"2017","journal-title":"Lancet Haematol"},{"key":"10.1016\/S1473-3099(20)30602-2_bib117","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1054\/drup.2001.0196","article-title":"Low-level antibacterial resistance: a gateway to clinical resistance","volume":"4","author":"Baquero","year":"2001","journal-title":"Drug Resist Updat"},{"key":"10.1016\/S1473-3099(20)30602-2_bib118","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-018-04059-1","article-title":"Evolution of high-level resistance during low-level antibiotic exposure","volume":"9","author":"Wistrand-Yuen","year":"2018","journal-title":"Nat Commun"},{"key":"10.1016\/S1473-3099(20)30602-2_bib119","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1038\/nrmicro3270","article-title":"Microbiological effects of sublethal levels of antibiotics","volume":"12","author":"Andersson","year":"2014","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/S1473-3099(20)30602-2_bib120","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms5344","article-title":"Tipping elements in the human intestinal ecosystem","volume":"5","author":"Lahti","year":"2014","journal-title":"Nat Commun"},{"key":"10.1016\/S1473-3099(20)30602-2_bib121","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1038\/s41559-018-0582-7","article-title":"Drug-mediated metabolic tipping between antibiotic resistant states in a mixed-species community","volume":"2","author":"Beardmore","year":"2018","journal-title":"Nat Ecol Evol"},{"key":"10.1016\/S1473-3099(20)30602-2_bib122","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms5544","article-title":"Streptococcus agalactiae clones infecting humans were selected and fixed through the extensive use of tetracycline","volume":"5","author":"Da Cunha","year":"2014","journal-title":"Nat Commun"},{"key":"10.1016\/S1473-3099(20)30602-2_bib123","series-title":"The evolving threat of antimicrobial resistance: options for action","year":"2012"},{"key":"10.1016\/S1473-3099(20)30602-2_bib124","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S1473-3099(12)70317-1","article-title":"The role of the natural environment in the emergence of antibiotic resistance in Gram-negative bacteria","volume":"13","author":"Wellington","year":"2013","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/S1473-3099(20)30602-2_bib125","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1111\/imj.12902","article-title":"Antibiotic resistance: are we all doomed?","volume":"45","author":"Collignon","year":"2015","journal-title":"Intern Med J"},{"key":"10.1016\/S1473-3099(20)30602-2_bib126","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1084\/jem.20181639","article-title":"Inhibiting antibiotic-resistant Enterobacteriaceae by microbiota-mediated intracellular acidification","volume":"216","author":"Sorbara","year":"2019","journal-title":"J Exp Med"},{"key":"10.1016\/S1473-3099(20)30602-2_bib127","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.chom.2016.03.004","article-title":"Depletion of butyrate-producing Clostridia from the gut microbiota drives an aerobic luminal expansion of Salmonella","volume":"19","author":"Rivera-Ch\u00e1vez","year":"2016","journal-title":"Cell Host Microbe"},{"key":"10.1016\/S1473-3099(20)30602-2_bib128","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1001\/jamainternmed.2016.3646","article-title":"The new antibiotic mantra\u2014\u201cShorter is better\u201d","volume":"176","author":"Spellberg","year":"2016","journal-title":"JAMA Intern Med"},{"key":"10.1016\/S1473-3099(20)30602-2_bib129","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1146\/annurev-pathol-011811-132421","article-title":"Human microbiome in health and disease","volume":"7","author":"Pflughoeft","year":"2012","journal-title":"Annu Rev Pathol"},{"key":"10.1016\/S1473-3099(20)30602-2_bib130","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/j.chom.2012.09.009","article-title":"Intestinal commensal microbes as immune modulators","volume":"12","author":"Ivanov","year":"2012","journal-title":"Cell Host Microbe"},{"key":"10.1016\/S1473-3099(20)30602-2_bib131","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1111\/j.1398-9995.2007.01462.x","article-title":"The role of the intestinal microbiota in the development of atopic disorders","volume":"62","author":"Penders","year":"2007","journal-title":"Allergy"},{"key":"10.1016\/S1473-3099(20)30602-2_bib132","first-page":"355","article-title":"Influence of the normal flora on mucosal morphology and cellular renewal in the ileum. A comparison of germ-free and conventional mice","volume":"12","author":"Abrams","year":"1963","journal-title":"Lab Invest"},{"key":"10.1016\/S1473-3099(20)30602-2_bib133","doi-asserted-by":"crossref","first-page":"427","DOI":"10.3389\/fimmu.2014.00427","article-title":"The intestinal microbiome in early life: health and disease","volume":"5","author":"Arrieta","year":"2014","journal-title":"Front Immunol"},{"key":"10.1016\/S1473-3099(20)30602-2_bib134","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.tins.2013.01.005","article-title":"Gut-brain axis: how the microbiome influences anxiety and depression","volume":"36","author":"Foster","year":"2013","journal-title":"Trends Neurosci"},{"key":"10.1016\/S1473-3099(20)30602-2_bib135","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.bbi.2009.05.058","article-title":"Mood and gut feelings","volume":"24","author":"Forsythe","year":"2010","journal-title":"Brain Behav Immun"},{"key":"10.1016\/S1473-3099(20)30602-2_bib136","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1007\/978-1-4939-0897-4_17","article-title":"The impact of microbiota on brain and behavior: mechanisms & therapeutic potential","volume":"817","author":"Borre","year":"2014","journal-title":"Adv Exp Med Biol"},{"key":"10.1016\/S1473-3099(20)30602-2_bib137","doi-asserted-by":"crossref","DOI":"10.1186\/s12879-019-4630-y","article-title":"Mathematical modelling for antibiotic resistance control policy: do we know enough?","volume":"19","author":"Knight","year":"2019","journal-title":"BMC Infect Dis"},{"key":"10.1016\/S1473-3099(20)30602-2_bib138","doi-asserted-by":"crossref","first-page":"e204","DOI":"10.1016\/S1473-3099(17)30478-4","article-title":"Use of mathematical modelling to assess the impact of vaccines on antibiotic resistance","volume":"18","author":"Atkins","year":"2018","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/S1473-3099(20)30602-2_bib139","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pcbi.1007211","article-title":"Mathematical model predicts anti-adhesion-antibiotic-debridement combination therapies can clear an antibiotic resistant infection","volume":"15","author":"Roberts","year":"2019","journal-title":"PLOS Comput Biol"},{"key":"10.1016\/S1473-3099(20)30602-2_bib140","author":"Fleming"}],"container-title":["The Lancet Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1473309920306022?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1473309920306022?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T09:33:47Z","timestamp":1761471227000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1473309920306022"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7]]},"references-count":138,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2021,7]]}},"alternative-id":["S1473309920306022"],"URL":"https:\/\/doi.org\/10.1016\/s1473-3099(20)30602-2","relation":{},"ISSN":["1473-3099"],"issn-type":[{"value":"1473-3099","type":"print"}],"subject":[],"published":{"date-parts":[[2021,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"To give or not to give antibiotics is not the only question","name":"articletitle","label":"Article Title"},{"value":"The Lancet Infectious Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S1473-3099(20)30602-2","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}